Source: http://feedproxy.google.com/~r/mnt/healthnews/~3/4OQyvsFWfZY/262357.php
Tuesday 25 June 2013
Progress Made In The Development Of A First-Generation Closed-Loop Insulin Delivery System
Animas Corporation has announced further promising results from the second phase of human clinical trials of a first-generation closed-loop insulin delivery system in development. Data investigating the predictive Hypoglycemia-Hyperglycemia Minimizer (HHM) System* demonstrated that the system is capable of maintaining safe glucose levels overnight. The data was presented at the 73rd Scientific Sessions of the American Diabetes Association (ADA) in Chicago, Illinois...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment